Literature DB >> 12537373

Development of a sequential enzymolysis approach for the evaluation of the bioaccessibility of Cd and Pb from cocoa.

S Mounicou1, J Szpunar, D Andrey, C Blake, R Lobinski.   

Abstract

An in vitro model simulating enzymatic activity in the gastrointestinal tract was developed for the assessment of the potential bioaccessibility of Cd and Pb in cocoa powder and liquor. The model was based on the sequential extraction with simulated gastric and intestinal juices; the residue after the latter extraction was further investigated by using, in parallel, solutions of phytase and cellulase. The solubility of Cd and Pb in the corresponding enzymatic extracts was measured by ICP MS. The bioaccessibility of Cd in cocoa varied from 10 to 50% in gastrointestinal conditions. An additional 20 or 30% of Cd could be recovered by phytase and cellulase, respectively. The bioaccessibility of Pb in gastrointestinal conditions did not exceed 5-10%. Only a few percent more of this metal could be recovered by extraction with phytase and cellulase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12537373     DOI: 10.1039/b207427n

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  3 in total

1.  Use of an in vitro digestion method to estimate human bioaccessibility of Cd in vegetables grown in smelter-impacted soils: the influence of cooking.

Authors:  Aurélie Pelfrêne; Christophe Waterlot; Annie Guerin; Nicolas Proix; Antoine Richard; Francis Douay
Journal:  Environ Geochem Health       Date:  2015-02-07       Impact factor: 4.609

2.  Lead contamination in selected foods from Riyadh city market and estimation of the daily intake.

Authors:  Zeid A Al Othman
Journal:  Molecules       Date:  2010-10-25       Impact factor: 4.411

3.  In Vitro and In Vivo Testing to Determine Cd Bioaccessibility and Bioavailability in Contaminated Rice in Relation to Mouse Chow.

Authors:  Shuo Sun; Xiaofang Zhou; Zhian Li; Ping Zhuang
Journal:  Int J Environ Res Public Health       Date:  2019-03-10       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.